What's Happening?
A recent study conducted by Harvard economics professor Rebecca Diamond has highlighted the social and economic benefits for women who lose weight using GLP-1 medications like Ozempic and Wegovy. The study, which is based on a large survey dataset, found
that women who used these medications were significantly more likely to secure employment and enter into relationships compared to those who did not. Specifically, non-working women on GLP-1s were 27 percentage points more likely to start a job, and 29 percentage points more likely to start living with a partner or get married within 18 months. The study suggests that obesity acts as a social and economic penalty, disproportionately affecting women. However, the study is a working paper and has not been peer-reviewed, and Diamond cautions against interpreting the findings as definitive evidence of weight discrimination.
Why It's Important?
The findings of this study underscore the pervasive impact of societal beauty standards on women's economic and social opportunities. The research suggests that weight loss can mitigate some of the penalties associated with obesity, potentially leading to improved job prospects and relationship opportunities. This highlights a broader issue of discrimination based on physical appearance, particularly in the labor market where such biases should not influence hiring decisions. The study also points to a disparity in access to GLP-1 medications, as those who can afford these treatments may gain an economic advantage, exacerbating existing inequalities. This raises important questions about the role of healthcare access in social mobility and economic equity.
What's Next?
As the conversation around weight discrimination and access to weight loss medications continues, there may be increased pressure on policymakers to address these disparities. This could involve expanding insurance coverage for GLP-1 medications or implementing policies to reduce discrimination based on physical appearance in hiring practices. Additionally, further research may be conducted to explore the long-term effects of weight loss on social and economic outcomes, as well as the ethical implications of using medication to conform to societal beauty standards.
